COUR Pharmaceuticals has been around a while, but not until last year did the company solidify behind its ultimate mission ...

As global markets edge toward record highs, driven by U.S. stock indexes and a surge in the Nasdaq Composite, investors are navigating a landscape marked by rising inflation and cautious monetary ...

Patients with localized muscle-invasive bladder cancer (MIBC) who received radiation plus the immune checkpoint inhibitors (ICIs) durvalumab (Imfinzi) and tremelimumab (Imjudo) had durable responses ...

The Sri Lanka Pharmaceutical Manufacturers Association (SLPMA) urged the government to create a level playing field for domestic pharmaceutical manufacturers to compete with imported pharmaceutical ...

Stuart Thomas talks about various strategies and practices that teams employ to integrate quality engineering into their ...

In this process, royalty recipients often face the issue where multiple small future royalty streams cannot fulfill ongoing large lump-sum R&D funding needs. The mismatch is where Royalty Pharma ...

As the demand for novel therapies and personalized medicine surges, leaders are uniquely positioned to create a culture of creativity, collaboration and innovation.

Hims & Hers hit the bullseye with its Super Bowl ad, sparking a surge in clicks to its site.The ad also hit a nerve with the ...

Data-driven insights powered by advanced analytics and artificial intelligence (AI) help optimise project schedules, allocate ...

Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look ...